Kintara Therapeutics Provides Positive Site Activation Update on GCAR Phase 2/3 Clinical Trial for Glioblastoma May 26, 2021
Kintara Therapeutics Announces Fiscal Third Quarter 2021 Financial Results and Provides Corporate Update May 14, 2021
Kintara Presents Updates on Two Phase 2 Clinical Trials at the 2021 American Association for Cancer Research Annual Meeting Apr 12, 2021
Kintara Therapeutics to Participate in Maxim Group's 2021 Emerging Growth Virtual Conference Mar 10, 2021
Kintara Therapeutics Appoints Dr. Mario Lacouture to Scientific Advisory Board for Cutaneous Metastatic Breast Cancer Mar 3, 2021
Kintara Therapeutics Enrolls Final Patient in Phase 2 Clinical Trial of VAL-083 for Recurrent GBM Feb 17, 2021
